Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma

Abstract Background: Electronic cigarettes (e-cig) known as electronic nicotine devices recently gained popularity among smokers. Despite many studies investigating their safety and toxicity, few examined the delivery of e-cig-derived nicotine and its metabolites in alternative biological fluids. Methods: We performed a randomized, crossover, and controlled clinical trial in nine healthy smokers. Nicotine (NIC), cotinine (COT), and trans-3′-hydroxycotinine (3-HCOT) were measured in plasma and oral fluid by liquid chromatography-tandem mass spectrometry after consumption of two consecutive e-cig administrations or two consecutive tobacco cigarettes. Results: NIC and its metabolites were detected both in oral fluid and plasma following both administration conditions. Concentrations in oral fluid resulted various orders of magnitude higher than those observed in plasma. Oral fluid concentration of tobacco cigarette and e-cig-derived NIC peaked at 15 min after each administration and ranged between 1.0 and 1396 μg/L and from 0.3 to 860 μg/L; those of COT between 52.8 and 110 μg/L and from 33.8 to 94.7 μg/L; and those of 3-HCOT between 12.4 and 23.5 μg/L and from 8.5 to 24.4 μg/L. The oral fluid to plasma concentration ratio of both e-cig- and tobacco cigarette-derived NIC peaked at 15 min after both administrations and correlated with oral fluid NIC concentration. Conclusions: The obtained results support the measurement of NIC and metabolites in oral fluid in the assessment of intake after e-cig use and appear to be a suitable alternative to plasma when monitoring nicotine delivery from e-cig for clinical and toxicological studies.

[1]  K. Farsalinos,et al.  Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: regulatory implications. , 2016, Addiction.

[2]  Betty C. Chen,et al.  Death following intentional ingestion of e-liquid , 2015, Clinical toxicology.

[3]  K. Farsalinos,et al.  Corrigendum: Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers) , 2015, Scientific Reports.

[4]  R. Pacifici,et al.  Successful Nicotine Intake in Medical Assisted Use of E-Cigarettes: A Pilot Study , 2015, International journal of environmental research and public health.

[5]  João Costa,et al.  [Analysis of the Cochrane Review: Electronic Cigarettes for Smoking Cessation and Reduction. Cochrane Database Syst Rev. 2014,12: CD010216]. , 2015, Acta medica portuguesa.

[6]  L. Dawkins,et al.  First- versus second-generation electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms. , 2015, Addiction.

[7]  G. Valacchi,et al.  Are E‐cigarettes a safe and good alternative to cigarette smoking? , 2015, Annals of the New York Academy of Sciences.

[8]  P. Talbot,et al.  Puffing Topography and Nicotine Intake of Electronic Cigarette Users , 2015, PloS one.

[9]  M. Forrester,et al.  Electronic cigarette exposures reported to Texas poison centers. , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[10]  T. Padhya,et al.  Electronic Nicotine Delivery Systems (“E-cigarettes”) , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[11]  J. Etter.  Levels of saliva cotinine in electronic cigarette users. , 2014, Addiction.

[12]  A. Hoffman,et al.  Electronic cigarettes and nicotine clinical pharmacology , 2014, Tobacco Control.

[13]  M. Drummond,et al.  Electronic cigarettes. Potential harms and benefits. , 2014, Annals of the American Thoracic Society.

[14]  Riccardo Polosa,et al.  Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review , 2014, Therapeutic advances in drug safety.

[15]  M. Onozawa,et al.  Good relationship between saliva cotinine kinetics and plasma cotinine kinetics after smoking one cigarette. , 2013, Regulatory toxicology and pharmacology : RTP.

[16]  M. Caruso,et al.  EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study , 2013, PloS one.

[17]  Konstantinos Kostikas,et al.  Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function , 2013, Inhalation toxicology.

[18]  T. Eissenberg,et al.  Clinical laboratory assessment of the abuse liability of an electronic cigarette. , 2012, Addiction.

[19]  J. Etter,et al.  Saliva cotinine levels in users of electronic cigarettes , 2011, European Respiratory Journal.

[20]  B. Fríguls,et al.  Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry. , 2011, Journal of pharmaceutical and biomedical analysis.

[21]  M. Huestis,et al.  High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry , 2010, Analytical and bioanalytical chemistry.

[22]  T. Eissenberg,et al.  A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[23]  H McRobbie,et al.  Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial , 2010, Tobacco Control.

[24]  Thomas Eissenberg,et al.  Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration , 2010, Tobacco Control.

[25]  R. Pacifici,et al.  Ultrasensitive detection of nicotine and cotinine in teeth by high-performance liquid chromatography/tandem mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[26]  S. Pichini,et al.  Determination of arecoline (areca nut alkaloid) and nicotine in hair by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[27]  H. Jones,et al.  Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. , 2005, Journal of analytical toxicology.

[28]  D. Kidwell,et al.  Testing for drugs of abuse in saliva and sweat. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[29]  N. Benowitz,et al.  Cotinine effects on nicotine metabolism , 1997, Clinical pharmacology and therapeutics.

[30]  Leon Kosmider,et al.  Nicotine levels in electronic cigarettes. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[31]  L. Dawkins,et al.  Acute electronic cigarette use: nicotine delivery and subjective effects in regular users , 2013, Psychopharmacology.

[32]  T. Eissenberg,et al.  Electronic cigarettes: effective nicotine delivery after acute administration. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[33]  N. Benowitz,et al.  Nicotine chemistry, metabolism, kinetics and biomarkers. , 2009, Handbook of experimental pharmacology.

[34]  N. Benowitz,et al.  Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. , 1994, The Journal of pharmacology and experimental therapeutics.